The role of mast cells in bone marrow diseases [3]

Journal of Clinical Pathology

Volumn 57, Issue 1, 2004, Pages 108-109

  Ozdemir O ^a   Savosan S ^a  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APLASTIC ANEMIA; BONE MARROW DISEASE; CELLULAR IMMUNITY; HUMAN; LETTER; MAST CELL; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC MASTOCYTOSIS;

ANEMIA, APLASTIC; BONE MARROW CELLS; HUMANS; MAST CELLS; MYELODYSPLASTIC SYNDROMES;

EID: 0347755435     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.57.1.108     Document Type: Letter

References (8)

1. Horny H-P, Greschniok A, Jordan J-H, et al. Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric study. J Clin Pathol 2003;56:103-6.
2. Kojima S, Matsuyama T, Kodera Y. Plasma levels and production of soluble stem cell factor by marrow stromal cells in patients with aplastic anaemia. Br J Haemotol 1997;99:440-6.
3. Jordan JH, Schernthaner GH, Fritsche-Polanz R, et al. Stem cell factor-induced bone marrow mast cell hyperplasia mimicking systemic mastocytosis (SM): histopathologic and morphologic evaluation with special reference to recently established SM-criteria. Leuk Lymphoma 2002;43:575-82.
4. Edwards KM, Kam CM, Powers JC, et al. The human cytotoxic T cell granule serine protease granzyme H has chymotrypsin-like (chymase) activity and is taken up into cytoplasmic vesicles reminiscent of granzyme B-containing endosomes. J Biol Chem 1999;274:30468-73.
5. Leskinen M, Wang Y, Leszczynski D, et al. Mast cell chymase induces apaptosis of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2001;21:516-22.
6. Ruoss SJ, Hartmann T, Caughey GH. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 1991;88:493-9.
7. Chien M, Abella E, Raboh R, et al. Mast cell persistence is associated with poor outcome in childhood severe aplastic anemia following immune suppression [abstract]. Presented in the 17th Annual Meeting of ASPH/O, Seattle, Washington, May 3-May 6, 2003. Pediatr Res 2003;53:292A.
8. Özdemir Ö, Ravindranath Y, Savaşan S. Evaluation of long-term liquid culture grown human bone marrow mast cell cytotoxicity against human leukemia cells [abstract]. (44th annual meeting of the American Society of Hematology, Philadelphia, Pennsylvania, December 6-10, 2002.) Blood 2002;100:45b.